Financials
- Market Capitalization 7.63 M
- Employee 8
- Founded 2013
- CEO Murthy Simhambhatla
- Website www.aeonbiopharma.com
- Headquarter Delaware, United States
- FIGI BBG00Z17HDW3
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4855 | BOLT Bolt Biotherapeutics, Inc. - Common Stock | 4.12 USD | +1.73% | +0.73% | -11.40% | -27.72% | 7.92 M USD | ||
| 4863 | ASBP Aspire Biopharma Holdings, Inc. - Common Stock | 6.05 USD | +0.33% | +4.67% | +13.94% | +287.82% | 7.84 M USD | ||
| 4874 | ERNA Ernexa Therapeutics Inc. - Common Stock | 6.67 USD | +10.07% | +6.89% | +10.61% | +1808.44% | 7.78 M USD | ||
| 4880 | PMCB PharmaCyte Biotech, Inc. - Common Stock | 0.70 USD | +1.45% | -4.11% | -11.39% | -35.19% | 7.51 M USD |
Frequently asked questions about AEON Biopharma, Inc. Class A Common Stock
What is the AEON Biopharma, Inc. Class A Common Stock stock price today?
The current price of AEON Biopharma, Inc. Class A Common Stock (AEON) is 0.29. Over the past 24 hours, the stock has changed by -17.14%. Follow the AEON chart for real-time price dynamics.
What is the stock ticker of AEON Biopharma, Inc. Class A Common Stock?
AEON Biopharma, Inc. Class A Common Stock trades under the ticker AEON. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is AEON Biopharma, Inc. Class A Common Stock stock going up?
AEON has changed by -55.38% over the last week, -56.72% over the last month, and -72.12% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was AEON Biopharma, Inc. Class A Common Stock net income for the last quarter?
AEON Biopharma, Inc. Class A Common Stock reported net income of -11.79 M for the last quarter. The previous quarter showed -37.14 M, which means net income changed by +68.24%.
How many employees does AEON Biopharma, Inc. Class A Common Stock have?
As of the latest available data, AEON Biopharma, Inc. Class A Common Stock has 8 employees. Workforce size can provide additional context about the company's scale and operations.
What is AEON Biopharma, Inc. Class A Common Stock EBITDA?
AEON Biopharma, Inc. Class A Common Stock EBITDA is -5.99 M, and its EBITDA margin is 7 881.58%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy AEON Biopharma, Inc. Class A Common Stock stock?
You can buy AEON Biopharma, Inc. Class A Common Stock (AEON) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in AEON Biopharma, Inc. Class A Common Stock stock?
Investing in AEON Biopharma, Inc. Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AEON chart and related analysis on metatrader.com as part of your research.